Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse Liability of Acurox in Subjects with History of Opioid Abuse
NCT00699010Phase 2Completed
- Sponsor
- Acura Pharmaceuticals, Inc.
- Start
- Mar 2008
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxycodone + niacin in pain (2 arms), sponsored by Acura Pharmaceuticals, Inc. Primary endpoint: Drug Like/Dislike Effect at 30 Minutes Post Dose. Started Mar 2008; status: completed.
02
Drugs
oxycodone + niacin
03
Conditions
pain
Beyond the preview
Go deeper on NCT00699010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00699010.